Data last refreshed 24 days ago — analysis may not reflect the latest market data

LIFLIF

US

NEUTRAL

$57.72

P/E

33.37

PEG

0.02

FCF Yield

Rev Growth YoY

+33.3% YoY

Gross Margin

77.1%

Health Score

6/10

D/E Ratio

0.57

Confidence

LOW


Advertisement

Business Snapshot

LIF provides no explicit business description in the provided data payload. The company appears to operate in an unspecified sector with its market cap unavailable, placing it outside standard market cap tier classifications at this time. The company reported TTM revenue is unavailable, making financial scale indeterminable from this dataset. What sets LIF apart is its earnings growth figure which is flagged as outside a plausible range, suggesting either a data source error or significant base-effect distortion, fundamentally complicating assessment of the company's trajectory.

Advertisement

Financial Health

Gross margin stands at a robust 77.1%, though no prior year comparison is available to determine direction. Net margin of 28.2% suggests strong profitability on whatever revenue the company generates...

Risk Assessment

  • VALUATION — P/E of 33.37x exceeds the sector average of 22x, reflecting a premium that may not be justified if growth decelerates.
  • EARNINGS QUALITY — Earnings growth of 1552.2% is flagged as outside a plausible range, indicating a likely data source error or base-effect distortion.
  • TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
  • INSIDER ACTIVITY — Insiders recorded 2 sells against 0 buys over the last 90 days, a net selling signal that warrants scrutiny.
  • VALUATION DIVERGENCE — Both DCF estimates (FMP and Python) are unavailable, leaving no fundamental anchor for assessing whether the current price represents fair value....

Gross margin stands at a robust 77.1%, though no prior year comparison is available to determine direction. Net margin of 28.2% suggests strong profitability on whatever revenue the company generates. The balance sheet appears healthy with a Debt/Equity ratio of 0.57x, indicating manageable leverage, while the current ratio of 6.26x points to ample short-term liquidity and a significant cash buffer. Return on equity of 31.4% is notably high, suggesting efficient capital allocation. Free cash flow is unavailable, making it impossible to assess the company's cash-generation sustainability or its capacity for dividends or reinvestment without external financing.

- VALUATION — P/E of 33.37x exceeds the sector average of 22x, reflecting a premium that may not be justified if growth decelerates. - EARNINGS QUALITY — Earnings growth of 1552.2% is flagged as outside a plausible range, indicating a likely data source error or base-effect distortion. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - INSIDER ACTIVITY — Insiders recorded 2 sells against 0 buys over the last 90 days, a net selling signal that warrants scrutiny. - VALUATION DIVERGENCE — Both DCF estimates (FMP and Python) are unavailable, leaving no fundamental anchor for assessing whether the current price represents fair value.

Unlock the full AI report

Full 8-section analysis includes:

Financial Health
Growth Momentum
Valuation Snapshot
Risk Flags
Sentiment & News
Technical Snapshot
Full Verdict with Confidence Rating
Last updated 581 hours ago · Data sourced from FMP & Finnhub · Not financial advice